Sleep Aids - Northern Africa

  • Northern Africa
  • Revenue in the Sleep Aids market amounts to US$6.42m in 2024. The market is expected to grow annually by 7.41% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$2,103m in 2024).
  • In relation to total population figures, per person revenues of US$0.02 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids market in Northern Africa is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in Northern Africa are increasingly seeking sleep aids to address their sleep-related issues. The hectic and stressful lifestyles of individuals in this region have contributed to a rise in sleep disorders and insomnia. As a result, there is a growing demand for sleep aids that can help improve sleep quality and promote relaxation.

Trends in the market:
One of the key trends in the Sleep Aids market in Northern Africa is the growing popularity of natural and herbal sleep aids. Customers are becoming more conscious of the potential side effects of synthetic sleep aids and are opting for natural alternatives. This trend is driven by the increasing availability of herbal sleep aids in the market and the perception that they are safer and have fewer adverse effects. Another trend in the market is the rising demand for sleep aids with advanced features. Customers are now looking for sleep aids that not only help them fall asleep but also monitor their sleep patterns, provide personalized recommendations, and track their overall sleep quality. This trend is fueled by advancements in technology and the increasing adoption of wearable devices and smart home technology in the region.

Local special circumstances:
Northern Africa has a unique cultural and religious landscape that influences customer preferences in the Sleep Aids market. For example, during the month of Ramadan, Muslims in this region fast from sunrise to sunset, which can disrupt their sleep patterns. As a result, there is a higher demand for sleep aids during this period to help individuals adjust to the changes in their sleep schedule.

Underlying macroeconomic factors:
The Sleep Aids market in Northern Africa is also influenced by underlying macroeconomic factors. The region has been experiencing economic growth, leading to an increase in disposable income among consumers. This has resulted in a higher purchasing power and affordability for sleep aids. Additionally, the growing middle class in Northern Africa has contributed to the expansion of the market as more individuals are able to afford sleep aids to improve their sleep quality. In conclusion, the Sleep Aids market in Northern Africa is growing due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for sleep aids is driven by the need to address sleep-related issues and improve sleep quality in a region with hectic lifestyles. As customers become more conscious of the potential side effects of synthetic sleep aids, there is a growing preference for natural and herbal alternatives. The market is also witnessing an increased demand for sleep aids with advanced features, driven by advancements in technology. The unique cultural and religious landscape of Northern Africa, along with the region's economic growth and rising disposable income, further contribute to the growth of the Sleep Aids market in this region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)